Groowe Groowe / Newsroom / CLDI
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CLDI News

Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

globenewswire.com
CLDI

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

globenewswire.com
CLDI

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9

accessnewswire.com
CLDI

Form 8-K

sec.gov
CLDWW CLDI

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting

globenewswire.com
CLDI

Calidi Biotherapeutics Provides Required NYSE American Disclosure

globenewswire.com
CLDI

Form 8-K

sec.gov
CLDWW CLDI

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

globenewswire.com
CLDI

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

globenewswire.com
CLDI

Form 8-K

sec.gov
CLDI CLDWW